Survivorship: Sexual Dysfunction (Male), Version 1.2013

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 12, Issue 3, 2014, Pages 356-363

  Denlinger, Crystal S ^a   Carlson, Robert W ^b   Are, Madhuri ^c   Scott Baker, K ^d   Davis, Elizabeth ^e   Edge, Stephen B ^f   Friedman, Debra L ^g   Goldman, Mindy ^h   Jones, Lee ⁱ   King, Allison ^j   Kvale, Elizabeth ^k   Langbaum, Terry S ^l   Ligibel, Jennifer A ^m   McCabe, Mary S ⁿ   McVary, Kevin T ^o   Melisko, Michelle ^h   Montoya, Jose G ^b   Mooney, Kathi ^p   Ann Morgan, Mary ^q   O’Connor, Tracey ^f   Paskett, Electra D ^r   Raza, Muhammad ^s   Syrjala, Karen L ^d   Urba, Susan G ^t   Wakabayashi, Mark T ^u   Zee, Phyllis ^o   McMillian, Nicole ^v   Freedman Cass, Deborah ^v   more..

^a FOX CHASE CANCER CENTER   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

^e Tewksbury Hospital   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g VANDERBILT INGRAM CANCER CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ DUKE CANCER INSTITUTE   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m Da na Farber Brigham and Women s Cancer Center   (United States)

ⁿ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^o NORTHWESTERN UNIVERSITY   (United States)

^p UNIVERSITY OF UTAH   (United States)

^q H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^r OHIO STATE UNIVERSITY   (United States)

^s UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^t UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^u CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^v NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERECTILE DYSFUNCTION; HUMAN; MALE; NEOPLASM; PRACTICE GUIDELINE; SURVIVOR;

ERECTILE DYSFUNCTION; HUMANS; MALE; NEOPLASMS; SURVIVORS;

EID: 84908257876     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2014.0037     Document Type: Article

References (27)

1. Bober SL, Varela VS. Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol 2012;30:3712–3719.
2. Donovan KA, Thompson LM, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control 2010;17:44–51.
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537–544.
4. Morreale MK. The impact of cancer on sexual function. Adv Psychosom Med 2011;31:72–82.
5. Vomvas D, Iconomou G, Soubasi E, et al. Assessment of sexual function in patients with cancer undergoing radiotherapy—a single centre prospective study. Anticancer Res 2012;32:657–664.
6. Forbat L, White I, Marshall-Lucette S, Kelly D. Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. BJU Int 2012;109:98–103.
7. White ID, Allan H, Faithfull S. Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy? Br J Cancer 2011;105:903–910.
8. Fink HA, Mac Donald R, Rutks IR, et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002;162:1349–1360.
9. Ganz PA, Greendale GA, Petersen L, et al. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 2000;92:1054–1064.
10. Nehra A. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc 2009;84:139–148.
11. Miles CL, Candy B, Jones L, et al. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007:CD005540.
12. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83–90.
13. The Management of Erectile Dysfunction (2005). American Urological Association Web site. Available at: http://www.auanet.org/education/guidelines/erectile-dysfunction.cfm. Accessed February 9, 2014.
14. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005;17:307–319.
15. Monga M, Bettencourt R, Barrett-Connor E. Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo study. Urology 2002;59:753–757.
16. Ellis R, Smith A, Wilson S, et al. The prevalence of erectile dysfunction in post-treatment colorectal cancer patients and their interests in seeking treatment: a cross-sectional survey in the west-midlands. J Sex Med 2010;7:1488–1496.
17. Hendren SK, O’Connor BI, Liu M, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212–223.
18. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358–1367.
19. Resnick MJ, Koyama T, Fan KH, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013;368:436–445.
20. Schover LR, Fouladi RT, Warneke CL, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002;95:1773–1785.
21. Siegel T, Moul JW, Spevak M, et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001;165:430–435.
22. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283:354–360.
23. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012;87:766–778.
24. Hubanks JM, Umbreit EC, Karnes RJ, Myers RP. Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series. Eur Urol 2012;61:878–884.
25. Yang L, Qian S, Liu L, et al. Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: a systematic review and meta-analysis. Urol Int 2012;90:339–347.
26. Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003;42:1855–1860.
27. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999;83:21C–28C.